SuperworthViridian Therapeutics market cap VRDN
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $2.5B
- Highest close in our data
- $3.2B
- Jan 2026
Viridian Therapeutics is worth $2.5B at the close on Oct 23, 2026, at $22.37 a share.
That is up 40% over the last year and up 1360% over five years.
Its highest close in our data was $3.2B in Jan 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.5B | $1.4B | $3.2B | −17% |
| 2025 | $3B | $977M | $3.1B | +97% |
| 2024 | $1.5B | $762.7M | $1.7B | +35% |
| 2023 | $1.1B | $505.7M | $1.5B | −3% |
| 2022 | $1.2B | $263.8M | $1.2B | +174% |
| 2021 | $429.5M | $62.8M | $467M | +568% |
| 2020 | $64.3M | $17M | $78M | +298% |
| 2019 | $16.1M | $14.6M | $118.7M | −80% |
| 2018 | $82.6M | $74M | $232.2M | −64% |
| 2017 | $232.7M | $3.6M | $318.7M | +6356% |
| 2016 | $3.6M | $2.5M | $7.5M | −55% |
| 2015 | $8M | $5.9M | $17.7M | −16% |
| 2014 | $9.5M | $9M | $19.7M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Viridian Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| VRDNViridian Therapeutics | $2.5B |
| NRIXNurix Therapeutics | $2.8B |
| PBHPrestige Consumer Healthcare | $2.3B |
| HRMYHarmony Biosciences | $2.1B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.8B |
| ANIPANI Pharmaceuticals | $1.7B |
| ARQTArcutis Biotherapeutics | $3.9B |
| INDVIndivior Pharmaceuticals | $4.1B |
| PAHCPhibro Animal Health | $1.6B |
| ANABAnaptysbio | $1.5B |
| Peer median | $2.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Viridian Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.